Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

134 ARTÍCULOS , VIENDO DEL 61 AL 75

Lessons from epidemiologic research about risk factors, modifiers, and progression of late onset Alzheimer's Disease in New York City at Columbia University Medical Center

Devanand D, Lee J, Luchsinger J, Manly J, Marder K, Mayeux R, Scarmeas N, Schupf N, Stern Y.

J Alzheimers Dis. 2013;33 Suppl 1(0 1):S447-55. doi: 10.3233/JAD-2012-129041.

Silicon-rich mineral water as a non-invasive test of the 'aluminum hypothesis' in Alzheimer's disease

Davenward S, Bentham P, Wright J, Crome P, Job D, Polwart A, Exley C.

J Alzheimers Dis. 2013;33(2):423-30. doi: 10.3233/JAD-2012-121231.

Mediterranean diet and dementia of the Alzheimer type

Vassallo N, Scerri C.

Curr Aging Sci. 2013 Jul;6(2):150-62. doi: 10.2174/1874609811306020003.

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

Liu CC, Liu CC, Kanekiyo T, Xu H, Bu G.

Nat Rev Neurol. 2013 Feb;9(2):106-18. doi: 10.1038/nrneurol.2012.263. Epub 2013 Jan 8.

Type 2 diabetes as a risk factor for Alzheimer's disease: the confounders, interactions, and neuropathology associated with this relationship

Vagelatos NT, Eslick GD.

Epidemiol Rev. 2013;35:152-60. doi: 10.1093/epirev/mxs012. Epub 2013 Jan 11.

Development of a new method for assessing global risk of Alzheimer's disease for use in population health approaches to prevention

Anstey KJ, Cherbuin N, Herath PM.

Prev Sci. 2013 Aug;14(4):411-21. doi: 10.1007/s11121-012-0313-2.

Alzheimer's disease and diabetes: new insights and unifying therapies

Vignini A, Giulietti A, Nanetti L, Raffaelli F, Giusti L, Mazzanti L, Provinciali L.

Curr Diabetes Rev. 2013 May;9(3):218-27. doi: 10.2174/1573399811309030003.

The association between APOE ε4 and Alzheimer-type dementia among memory clinic patients is confined to those with a higher education. The DESCRIPA Study

Vermeiren AP, Bosma H, Visser PJ, Zeegers MP, Graff C, Ewers M, Frisoni GB, Frölich L, Hampel H, Jones RW, Kehoe PG, Lenoir H, Minthon L, Nobili FM, Olde Rikkert M, Rigaud AS, Scheltens P, Soininen H, Spiru L, Tsolaki M, Wahlund LO, Vellas B, Wilcock G, Elias-Sonnenschein LS, Verhey FR.

J Alzheimers Dis. 2013;35(2):241-6. doi: 10.3233/JAD-122182.

Nutrition and neurodegeneration: epidemiological evidence and challenges for future research

Gillette-Guyonnet S, Secher M, Vellas B.

Br J Clin Pharmacol. 2013 Mar;75(3):738-55. doi: 10.1111/bcp.12058.

Genetic variation in clusterin gene and Alzheimer's disease risk in Han Chinese

Yu JT, Ma XY, Wang YL, Sun L, Tan L, Hu N, Tan L.

Neurobiol Aging. 2013 Jul;34(7):1921.e17-23. doi: 10.1016/j.neurobiolaging.2013.01.010. Epub 2013 Feb 12.

A 12-week multidomain intervention versus active control to reduce risk of Alzheimer's disease: study protocol for a randomized controlled trial

Anstey KJ, Bahar-Fuchs A, Herath P, Rebok GW, Cherbuin N.

Trials. 2013 Feb 27;14:60. doi: 10.1186/1745-6215-14-60.

Equal sensitivity of early and late scans after injection of FDG for the detection of Alzheimer pattern: an analysis of 3D PET data from J-ADNI, a multi-center study

Takahashi R, Ishii K, Senda M, Ito K, Ishii K, Kato T, Makishi Y, Nishio T, Ikari Y, Iwatsubo T; Japanese Alzheimer’s Disease Neuroimaging Initiative.

Ann Nucl Med. 2013 Jun;27(5):452-9. doi: 10.1007/s12149-013-0704-x. Epub 2013 Mar 13.

Cognitive impairment and diabetes

Dash SK.

Recent Pat Endocr Metab Immune Drug Discov. 2013 May;7(2):155-65. doi: 10.2174/1872214811307020009.

Utility of the AD8 as a self-rating tool for cognitive impairment in an Asian population

Chin R, Ng A, Narasimhalu K, Kandiah N.

Am J Alzheimers Dis Other Demen. 2013 May;28(3):284-8. doi: 10.1177/1533317513481090. Epub 2013 Mar 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias